Gene · 2235
Papers1,987
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
381 to 400 of 1,987
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Athena speciality certificate examination case for photodermatology. | Clin Exp Dermatol | 2022 | 35474335 | PubTator, text mining | PubMed |
| The role of the genetic variant FECH rs11660001 in the occurrence of anti-tuberculosis drug-induced liver injury. | J Clin Pharm Ther | 2022 | 35470464 | PubTator, text mining | PubMed |
| Mechanisms of Resistance to Photodynamic Therapy (PDT) in Vulvar Cancer. | Int J Mol Sci | 2022 | 35456936 | PubTator, text mining | PubMed |
| Comparative Genomic Hybridization to Microarrays in Fetuses with High-Risk Prenatal Indications: Polish Experience with 7400 Pregnancies. | Genes (Basel) | 2022 | 35456496 | PubTator, text mining | PubMed |
| Loss and Recovery of Glutaredoxin 5 Is Inducible by Diet in a Murine Model of Diabesity and Mediated by Free Fatty Acids In Vitro. | Antioxidants (Basel) | 2022 | 35453472 | PubTator, text mining | PubMed |
| Erythropoietic Protoporphyria: You May Not Have Seen It, but It May Have Seen You. | Cureus | 2022 | 35449677 | PubTator, text mining | PubMed |
| Environmental induced transgenerational inheritance impacts systems epigenetics in disease etiology. | Sci Rep | 2022 | 35440735 | PubTator, text mining | PubMed |
| Recurrent transcriptional responses in AML and MDS patients treated with decitabine. | Exp Hematol | 2022 | 35429619 | PubTator, text mining | PubMed |
| Tumor microenvironment-aware, single-transcriptome prediction of microsatellite instability in colorectal cancer using meta-analysis. | Sci Rep | 2022 | 35428835 | PubTator, text mining | PubMed |
| Synthesis and applications of [60]fullerene nanoconjugate with 5-aminolevulinic acid and its glycoconjugate as drug delivery vehicles. | RSC Adv | 2022 | 35424628 | PubTator, text mining | PubMed |
| Role of phlebotomy in the treatment of liver damage related to erythropoietic porphyria. | Sci Rep | 2022 | 35414164 | PubTator, text mining | PubMed |
| Future Perspectives in Oxidative Stress in Trisomy 13 and 18 Evaluation. | J Clin Med | 2022 | 35407395 | PubTator, text mining | PubMed |
| Inhibition of ABCG2 transporter by lapatinib enhances 5-aminolevulinic acid-mediated protoporphyrin IX fluorescence and photodynamic therapy response in human glioma cell lines. | Biochem Pharmacol | 2022 | 35390338 | PubTator, text mining | PubMed |
| 5-Aminolevulinic acid overcomes hypoxia-induced radiation resistance by enhancing mitochondrial reactive oxygen species production in prostate cancer cells. | Br J Cancer | 2022 | 35365766 | PubTator, text mining | PubMed |
| A three-gene cluster in Trichoderma reesei reveals a potential role of dmm2 in DNA repair and cellulase production. | Biotechnol Biofuels Bioprod | 2022 | 35351200 | PubTator, text mining | PubMed |
| Bioinformatics Identification of Candidate Biomarkers in Endomyocardial Biopsy and Peripheral Blood for Cardiac Allograft Rejection. | Ann Transplant | 2022 | 35347104 | PubTator, text mining | PubMed |
| Cutting-Edge Therapies and Novel Strategies for Acute Intermittent Porphyria: Step-by-Step towards the Solution. | Biomedicines | 2022 | 35327450 | PubTator, text mining | PubMed |
| Exploiting Shock Waves to Trigger the Anticancer Sonodynamic Activity of 5-Aminolevulinc Acid-Derived Protoporphyrin IX on In Vitro 2D and 3D Cancer Models. | Biomedicines | 2022 | 35327417 | PubTator, text mining | PubMed |
| Photodynamic Antibiofilm and Antibacterial Activity of a New Gel with 5-Aminolevulinic Acid on Infected Titanium Surfaces. | Biomedicines | 2022 | 35327374 | PubTator, text mining | PubMed |
| Pythium insidiosum keratitis - A review. | Indian J Ophthalmol | 2022 | 35325996 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2235/papers?page=20